449 Pittsfield Rd
Lenox, MA 01240
Ross Baldessarini, M.D., is Professor of Psychiatry and in Neuroscience at Harvard Medical School and Director Emeritus of the Psychopharmacology Program and Director of the International Consortium for Psychotic and Bipolar Disorders at McLean Hospital. Dr. Baldessarini is known for his research and teaching in psychopharmacology and general psychiatry. He is the author of over 2,200 scientific papers and several books, including Chemotherapy in Psychiatry: Principles and Practice, 3rd edition (2013), and for many years the chapters on psychopharmaology in the standard textbook of pharmacology, Goodman & Gilman’s The Pharmacological Basis of Therapeutics. He has served on many editorial boards, including that of the American Journal of Psychiatry and JAMA Psychiatry. For his exceptional teaching skills, Dr. Baldessarini was awarded the first prestigious NEEI Mental Health Educator of the Year award.
Dr. Baldessarini’s symposium will review the current status of psychotropic drug treatment of psychotic and major mood disorders, with an emphasis on the research base on which sound clinical practice rests. Participants will learn an integration of research findings and relate these to principles of informed clinical decision-making so as to enhance treatment effectiveness and safety. Participants will learn an updated view of the chemical nature of agents in each class, their major actions, and disposition, short- and long-term clinical treatment, including applications in pediatric and geriatric practice, risks of adverse effects, and emerging advances in new and experimental treatments.